Port Washington, NY - Drive DeVilbiss Healthcare (DDH), a leading provider of respiratory products for more than 135 years, is mobilizing its resources to address the supply gap resulting from Philips Respironics' Thursday announcement that it will not return to the sale of portable and stationary oxygen concentrators in the United States.
Strategic infrastructure investments implemented during the pandemic will allow DDH to meet market demands with agility and efficiency. The company's Somerset, Penn. respiratory production facility, which underwent significant expansion during COVID-19, is primed to increase concentrator output to address industry needs, with concentrator production lines already set up.
"Our proactive approach to infrastructure development during the pandemic has positioned us to effectively address the current market dynamics," said Derek Lampert, Chief Executive Officer. "The enhancements made to our operations allow us to quickly ramp up production and meet customer needs for this critical equipment with little delay."
DDH is committed to delivering uninterrupted support and unparalleled reliability with its line of domestically assembled oxygen concentrators including the 525 5L stationary concentrator, 1025DS 10L stationary concentrator, and iGo®2 portable oxygen concentrator. For more information, visit drivemedical.com/oxygenpartner.
"Our concern for patients, public health, and the continued supply of oxygen products is paramount," added Lampert. "Our team is fully prepared to assist customers in navigating through this transition and ensuring seamless access to essential healthcare products."
About Drive DeVilbiss Healthcare
Headquartered in Port Washington, New York, Drive DeVilbiss Healthcare manufactures a complete line of medical products, including mobility products, respiratory products, beds, bariatric products, wheelchairs, sleep surfaces and pressure prevention products, self‐assist products, power-operated wheelchairs, rehabilitation products, resident room equipment, personal care products, and electrotherapy devices. Currently, the Company has corporate offices, manufacturing facilities, and distribution facilities located throughout the United States, Canada, the United Kingdom, France, Germany, China, Hong Kong, Romania, Australia, the Netherlands, and India. The Company markets its products to customers located throughout the United States, Europe, Canada, Mexico, Central, and South America, the Middle East, and Asia. For more information, visit www.drivemedical.com.